Developer docs
API playgroundTry for free, no card

Search company profiles

Nuclear Laser Medicine

Full company profile

uuid002vsjf

Namestring
Nuclear Laser Medicine
Legal namestring
Nuclear Laser Medicine srl
Websiteurl
nlm.it
Company typeenum
Private
Founded yearint
1984
Descriptiontext

Nuclear Laser Medicine srl (NLM) is an Italian in vitro diagnostics (IVD) company founded in 1984 and headquartered in Settala, Milan, Italy. With 40 years of operating history and a workforce of 11–50 employees, NLM develops, manufactures, and distributes molecular diagnostic kits, reagents, and automated instruments for clinical and research laboratories across infectious disease, genetics, oncology, and HLA testing applications. The company operates as both an OEM manufacturer of proprietary assays and a value-added distributor of complementary partner products in the Italian and broader European market.

NLM's product portfolio spans Real Time PCR kits built on FRET chemistry, fragment analysis kits using Fluorescent ARMS technology, Reverse Dot Blot (RDB) hybridization assays, and the OMNIA LH 75 PRO automated workstation for nucleic acid extraction and PCR setup. The company also operates NGS on! Whole Exome Analysis, a sequencing service line launched in 2024, and maintains a proprietary interpretive software suite including Real Gene, Real-PHARMA, IntRa-Q, and Genetic Fragment Analyzer. Products are sold under trademarks such as Genvinset, CF FAST, and a dedicated HLA kit line, indicating a branded catalog approach across multiple specialty diagnostic segments.

The commercial model combines direct B2B sales of proprietary kits and instruments with distribution partnerships that bring in partner products (DNA Diagnostics, Blackhills Diagnostic Resources, R-biopharm, Panagene, Protrans, BDR, Masmec). Go-to-market is event-driven (MEDICA, Medlab Middle East, ECCMID) and channel-driven, targeting clinical molecular biology labs, medical genetics centers, and clinical microbiology labs. Revenue mechanics rely on consumable and reagent sales tied to instrument placements, supplemented by distribution margins on partner products and a growing international distributor network. NLM holds ISO 9001:2015, ISO 13485:2016/A11:2021, and IVDR 2017/746/UE compliance with CE-IVDR marked products, and participates in UK NEQAS, CF Network, and INSTAND e.V. EQA schemes.

Short descriptiontext

Nuclear Laser Medicine srl is an Italian in vitro diagnostics company founded in 1984 that develops molecular diagnostic kits, automated instruments, and interpretive software for clinical and research laboratories in infectious disease, genetics, oncology, and HLA testing across Europe and select international markets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPetralia Sottana, Italy
HQ citystring
Petralia Sottana
HQ countrystring
Italy
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
in vitro diagnostics, molecular diagnostics kits, real time PCR assays, genetic testing solutions, automated laboratory workstations
Industry1 code
PRIMARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
NAICS code1 code
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Molecular Diagnostics
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Diagnostic Kits and Reagents
TypeOne Time License
Description

Sale of in vitro diagnostic kits for molecular biology testing including Real Time PCR kits, fragment analysis reagents, and reverse dot blot assays for infectious diseases, genetics, oncology, and HLA applications.

nlm.it
2Automated Instruments
TypeHardware Sales
Description

Sale and distribution of automated laboratory workstations including the OMNIA LH 75 PRO for nucleic acid extraction and PCR setup.

nlm.it
3Distribution Partnerships
TypeOne Time License
Description

Revenue from distributing partner products in Italy including R-biopharm, DNA Diagnostics, Panagene, Protrans, Blackhills Diagnostics Resources, and Masmec Biomedical products.

nlm.it
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1OMNIA System
Description

Compact workstation for nucleic acid extraction and PCR setup, designed for molecular biology laboratory automation.

nlm.it
+1 more record
Core offering1 text field

Nuclear Laser Medicine develops, manufactures, and distributes in vitro diagnostic kits and reagents for molecular biology laboratories, including Real Time PCR assays, fragment analysis tests, and reverse dot blot hybridization kits covering infectious diseases, genetics, oncology, and HLA applications. The company also produces the OMNIA LH 75 PRO automated workstation for nucleic acid extraction and PCR setup, and serves as the official Italian distributor for multiple international diagnostics manufacturers (DNA Diagnostics, R-biopharm, Panagene, Protrans, Blackhills Diagnostic Resources, Masmec Biomedical).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 100% sensitivity and specificity reported for SMA screening kits (IntRaFast-Q)
+1 more record
Product overview1 text field

Nuclear Laser Medicine offers an integrated portfolio of in vitro diagnostic solutions centered on the OMNIA LH 75 PRO automated workstation for nucleic acid extraction and PCR setup, complemented by an extensive menu of Real Time PCR, fragment analysis, and reverse dot blot (RDB) diagnostic kits. The product portfolio spans pharmacogenetics (DPYD, UGT1A1 tests for personalized drug therapy), cystic fibrosis (CF FAST, CF FAST Plus, AC023/25, CF Plus, CF del), hemoglobinopathies (Alpha/Beta Globin Tests), hemochromatosis (HFE mutation panels), cardiovascular disease (CVD-6 Multiplex, Factor II/V, MTHFR, PAI-1, ApoE), and infectious diseases (SARS-CoV-2, HCV genotyping/quantification, Chlamydia, CMV, EBV, HSV-1/2, HHV-6, VZV, Enterovirus). The company also distributes third-party products including SMA screening kits, Fragile X tests (Adellgene), and DNA Diagnostics' Hemavision leukemia translocation panels. Quality management is certified to ISO 9001:2015 and ISO 13485:2016 standards.

Product and service10 records
1OMNIA LH 75 PRO Workstation
CategoryLaboratory Instrumentation
Description

Automated workstation for nucleic acid extraction and PCR setup using magnetic bead-based technology, with bidirectional LIS connectivity, touchscreen interface, and barcode reading. Designed for clinical molecular biology laboratories handling routine and mid-throughput workflows.

2Real Time PCR Diagnostic Kits (FRET Technology)
CategoryMolecular Diagnostic Reagents
Description

CE-IVDR marked Real Time PCR kits using FRET melting curve analysis covering infectious diseases (Chlamydia trachomatis, CMV, EBV, HSV-1/2, HHV-6, VZV, Enterovirus, SARS-CoV-2), pharmacogenetics (DPYD, UGT1A1), coagulation and thrombophilia (Factor II/V, MTHFR, PAI-1), hemochromatosis (HFE), HCV genotyping, and other applications.

3Reverse Dot Blot (RDB) Strip Assays
CategoryMolecular Diagnostic Reagents
Description

Strip-based reverse dot blot hybridization kits for detection of alpha and beta thalassemias, thrombophilia (CVD-14 Multiplex), celiac disease HLA typing (CeLia-Type Strip Assay), and other genetic variations. Includes proprietary interpretive software for automated result analysis.

4CF FAST Fragment Analysis Kits
CategoryMolecular Diagnostic Reagents
Description

Fragment analysis kits using Fluorescent ARMS technology for detection of CFTR gene mutations causing cystic fibrosis, designed for use on automated sequencers with rapid turnaround.

5NGS on! Whole Exome Sequencing Service
CategoryGenomic Services
Description

Whole Exome Sequencing service performed at NLM's laboratory, providing comprehensive genetic profiling for medical genetics applications with interpretation support.

6IntRaFast-Q SMA Screening Kits
CategoryMolecular Diagnostic Reagents
Description

Real Time PCR kits for newborn screening and carrier screening of Spinal Muscular Atrophy (SMA), including SMN1 exon 7, SMN1 exon 8, and SMN2 copy number detection.

7Hemavision Leukemia Translocation Panels
CategoryMolecular Diagnostic Reagents
Description

Distributed from DNA Diagnostics (Denmark), the Hemavision 7Q and 28Q kits detect chromosomal translocations and gene rearrangements in leukemia using multiplex PCR with fragment analysis.

8Adellgene Fragile X Test Kit
CategoryMolecular Diagnostic Reagents
Description

Distributed from Blackhills Diagnostic Resources, the Adellgene kit detects CGG repeat expansions in the FMR1 gene associated with Fragile X syndrome.

9ULTRAPLEX ALLIANCE System
CategoryLaboratory Instrumentation
Description

Automated nucleic acid extraction and PCR setup system distributed from Masmec Biomedical, designed to support high-throughput molecular diagnostic workflows.

10NLM PPE Face Masks
CategoryMedical Supplies
Description

Personal protective equipment face masks produced by NLM, reflecting the company's diversification into medical supplies alongside its diagnostics portfolio.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2023-01-01
Description

NLM serves as the official Italian distributor for DNA Diagnostics, a Danish company founded in 1992 specializing in PCR and qPCR kit production for clinical and research laboratories. The partnership provides Italian customers with DNA Diagnostics' products including Hemavision 7Q and Hemavision 28Q for leukemia translocation detection using Real Time PCR technology.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

NLM distributes R-biopharm products in Italy. R-biopharm is a German company specializing in clinical diagnostics and food analysis solutions.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

NLM distributes Panagene products in Italy. Panagene is a Korean company specializing in molecular biology reagents and instruments.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

NLM distributes Protrans products in Italy. Protrans is a German company specializing in transplantation diagnostics and HLA typing solutions.

5Blackhills Diagnostics Resources (BDR)
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

NLM is the official Italian distributor for Blackhills Diagnostics Resources (BDR), a Spanish company. NLM distributes BDR products including the Adellgene Fragile X kit for FMR1 gene analysis. The partnership has been renewed multiple times.

nlm.it
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

NLM distributes Masmec Biomedical products in Italy. Masmec Biomedical is an Italian company specializing in biomedical instruments and diagnostics.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global life science and clinical diagnostics company with a broad molecular diagnostics portfolio including real-time PCR kits and instruments (e.g., CFX96) that NLM products are validated on. Comparable as a larger incumbent offering overlapping IVD menu categories to the same lab customers.

TypeBroad incumbent
Description

Developer of the GeneXpert fully integrated PCR systems and broad menu of CE-marked molecular diagnostic tests for infectious disease and oncology. Comparable as a larger incumbent in automated molecular IVD workflows targeting the same hospital lab segment NLM addresses.

TypeDirect peer
Description

Danish manufacturer of PCR and qPCR kits for clinical and research laboratories, including leukemia translocation panels (Hemavision). Highly comparable as a small specialist peer, and also an NLM partner whose products NLM distributes in Italy.

TypeDirect peer
Description

Italy-based IVD company focused on immunodiagnostics and molecular diagnostics, including reagents, instruments and consumables. Comparable as a domestic Italian IVD peer with an established international footprint and similarly hospital- and lab-focused channels.

TypeBroad incumbent
Description

Global leader in sample-preparation and PCR-based molecular diagnostic kits and automation platforms for clinical and research labs. Comparable as a broader incumbent in IVD molecular workflows, including nucleic acid extraction and PCR setup where NLM's OMNIA competes.

TypeDirect peer
Description

Italian IVD manufacturer focused on molecular diagnostics kits, including real-time PCR assays for infectious disease and genetic testing. Closely comparable as a small Italy-headquartered competitor serving the same clinical lab customer base with overlapping menus.

TypeDirect peer
Description

German clinical diagnostics manufacturer producing PCR and immunoassay kits for infectious disease and food/clinical analysis. Directly comparable as a same-tier European IVD kit specialist, and NLM is already an Italian distributor for R-biopharm products.

TypeDirect peer
Description

European-headquartered specialist in clinical molecular diagnostics IVD kits and instruments serving hospital and independent laboratories. Closely comparable to NLM in scale, menu breadth across infectious disease and genetic testing, and distribution-led commercial model.

TypeBroad incumbent
Description

Major molecular diagnostics company with a strong menu of women's health and infectious disease PCR assays sold to hospital and reference labs. Comparable as a broader incumbent serving overlapping clinical lab end-markets with CE-IVDR marked molecular kits.

10Fujirebio (H.U. Group Holdings)
TypeBroad incumbent
Description

Japanese-headquartered IVD company producing clinical diagnostics kits and instruments across infectious disease, oncology and genetic testing. Comparable as a broader incumbent with overlapping molecular IVD menu items and CE-IVDR market presence.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration6 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Nuclear Laser Medicine

Molecular Diagnosticsnlm.it

Nuclear Laser Medicine srl is an Italian in vitro diagnostics company founded in 1984 that develops molecular diagnostic kits, automated instruments, and interpretive software for clinical and research laboratories in infectious disease, genetics, oncology, and HLA testing across Europe and select international markets.

What Nuclear Laser Medicine does

Nuclear Laser Medicine srl (NLM) is an Italian in vitro diagnostics (IVD) company founded in 1984 and headquartered in Settala, Milan, Italy. With 40 years of operating history and a workforce of 11–50 employees, NLM develops, manufactures, and distributes molecular diagnostic kits, reagents, and automated instruments for clinical and research laboratories across infectious disease, genetics, oncology, and HLA testing applications. The company operates as both an OEM manufacturer of proprietary assays and a value-added distributor of complementary partner products in the Italian and broader European market.

NLM's product portfolio spans Real Time PCR kits built on FRET chemistry, fragment analysis kits using Fluorescent ARMS technology, Reverse Dot Blot (RDB) hybridization assays, and the OMNIA LH 75 PRO automated workstation for nucleic acid extraction and PCR setup. The company also operates NGS on! Whole Exome Analysis, a sequencing service line launched in 2024, and maintains a proprietary interpretive software suite including Real Gene, Real-PHARMA, IntRa-Q, and Genetic Fragment Analyzer. Products are sold under trademarks such as Genvinset, CF FAST, and a dedicated HLA kit line, indicating a branded catalog approach across multiple specialty diagnostic segments.

The commercial model combines direct B2B sales of proprietary kits and instruments with distribution partnerships that bring in partner products (DNA Diagnostics, Blackhills Diagnostic Resources, R-biopharm, Panagene, Protrans, BDR, Masmec). Go-to-market is event-driven (MEDICA, Medlab Middle East, ECCMID) and channel-driven, targeting clinical molecular biology labs, medical genetics centers, and clinical microbiology labs. Revenue mechanics rely on consumable and reagent sales tied to instrument placements, supplemented by distribution margins on partner products and a growing international distributor network. NLM holds ISO 9001:2015, ISO 13485:2016/A11:2021, and IVDR 2017/746/UE compliance with CE-IVDR marked products, and participates in UK NEQAS, CF Network, and INSTAND e.V. EQA schemes.

Nuclear Laser Medicine firmographics

Firmographics
Name
Nuclear Laser Medicine
Legal name
Nuclear Laser Medicine srl
Website
https://nlm.it
Company type
Private
Founded year
1984
Operating status
Operating
Headcount range
11–50 employees
Short description
Nuclear Laser Medicine srl is an Italian in vitro diagnostics company founded in 1984 that develops molecular diagnostic kits, automated instruments, and interpretive software for clinical and research laboratories in infectious disease, genetics, oncology, and HLA testing across Europe and select international markets.
Ownership category
akta.pro rank

Nuclear Laser Medicine industry classification

Industry
Product category
Molecular Diagnostics
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)

Keywords

  • In vitro diagnostics
  • Molecular diagnostics kits
  • Real time PCR assays
  • Genetic testing solutions
  • Automated laboratory workstations

Where Nuclear Laser Medicine is headquartered

Location

Headquarters

HQ city
Petralia Sottana
HQ country
Italy
HQ region
Europe

Offices1 record

Markets served

Nuclear Laser Medicine business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Others

Revenue model

  1. Diagnostic Kits and Reagents: Sale of in vitro diagnostic kits for molecular biology testing including Real Time PCR kits, fragment analysis reagents, and reverse dot blot assays for infectious diseases, genetics, oncology, and HLA applications.
  2. Automated Instruments: Sale and distribution of automated laboratory workstations including the OMNIA LH 75 PRO for nucleic acid extraction and PCR setup.
  3. Distribution Partnerships: Revenue from distributing partner products in Italy including R-biopharm, DNA Diagnostics, Panagene, Protrans, Blackhills Diagnostics Resources, and Masmec Biomedical products.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Nuclear Laser Medicine product offering

Product offering

Core offering

Nuclear Laser Medicine develops, manufactures, and distributes in vitro diagnostic kits and reagents for molecular biology laboratories, including Real Time PCR assays, fragment analysis tests, and reverse dot blot hybridization kits covering infectious diseases, genetics, oncology, and HLA applications. The company also produces the OMNIA LH 75 PRO automated workstation for nucleic acid extraction and PCR setup, and serves as the official Italian distributor for multiple international diagnostics manufacturers (DNA Diagnostics, R-biopharm, Panagene, Protrans, Blackhills Diagnostic Resources, Masmec Biomedical).

Product overview

Nuclear Laser Medicine offers an integrated portfolio of in vitro diagnostic solutions centered on the OMNIA LH 75 PRO automated workstation for nucleic acid extraction and PCR setup, complemented by an extensive menu of Real Time PCR, fragment analysis, and reverse dot blot (RDB) diagnostic kits. The product portfolio spans pharmacogenetics (DPYD, UGT1A1 tests for personalized drug therapy), cystic fibrosis (CF FAST, CF FAST Plus, AC023/25, CF Plus, CF del), hemoglobinopathies (Alpha/Beta Globin Tests), hemochromatosis (HFE mutation panels), cardiovascular disease (CVD-6 Multiplex, Factor II/V, MTHFR, PAI-1, ApoE), and infectious diseases (SARS-CoV-2, HCV genotyping/quantification, Chlamydia, CMV, EBV, HSV-1/2, HHV-6, VZV, Enterovirus). The company also distributes third-party products including SMA screening kits, Fragile X tests (Adellgene), and DNA Diagnostics' Hemavision leukemia translocation panels. Quality management is certified to ISO 9001:2015 and ISO 13485:2016 standards.

Differentiator

Problem solved

Functional benefit

Brands

  • OMNIA System: Compact workstation for nucleic acid extraction and PCR setup, designed for molecular biology laboratory automation.
  • NGS on!®

Products and services

  • OMNIA LH 75 PRO Workstation Automated workstation for nucleic acid extraction and PCR setup using magnetic bead-based technology, with bidirectional LIS connectivity, touchscreen interface, and barcode reading. Designed for clinical molecular biology laboratories handling routine and mid-throughput workflows.
  • Real Time PCR Diagnostic Kits (FRET Technology) CE-IVDR marked Real Time PCR kits using FRET melting curve analysis covering infectious diseases (Chlamydia trachomatis, CMV, EBV, HSV-1/2, HHV-6, VZV, Enterovirus, SARS-CoV-2), pharmacogenetics (DPYD, UGT1A1), coagulation and thrombophilia (Factor II/V, MTHFR, PAI-1), hemochromatosis (HFE), HCV genotyping, and other applications.
  • Reverse Dot Blot (RDB) Strip Assays Strip-based reverse dot blot hybridization kits for detection of alpha and beta thalassemias, thrombophilia (CVD-14 Multiplex), celiac disease HLA typing (CeLia-Type Strip Assay), and other genetic variations. Includes proprietary interpretive software for automated result analysis.
  • CF FAST Fragment Analysis Kits Fragment analysis kits using Fluorescent ARMS technology for detection of CFTR gene mutations causing cystic fibrosis, designed for use on automated sequencers with rapid turnaround.
  • NGS on! Whole Exome Sequencing Service Whole Exome Sequencing service performed at NLM's laboratory, providing comprehensive genetic profiling for medical genetics applications with interpretation support.
  • IntRaFast-Q SMA Screening Kits Real Time PCR kits for newborn screening and carrier screening of Spinal Muscular Atrophy (SMA), including SMN1 exon 7, SMN1 exon 8, and SMN2 copy number detection.
  • Hemavision Leukemia Translocation Panels Distributed from DNA Diagnostics (Denmark), the Hemavision 7Q and 28Q kits detect chromosomal translocations and gene rearrangements in leukemia using multiplex PCR with fragment analysis.
  • Adellgene Fragile X Test Kit Distributed from Blackhills Diagnostic Resources, the Adellgene kit detects CGG repeat expansions in the FMR1 gene associated with Fragile X syndrome.
  • ULTRAPLEX ALLIANCE System Automated nucleic acid extraction and PCR setup system distributed from Masmec Biomedical, designed to support high-throughput molecular diagnostic workflows.
  • NLM PPE Face Masks Personal protective equipment face masks produced by NLM, reflecting the company's diversification into medical supplies alongside its diagnostics portfolio.

Quantifiable outcome

  • 100% sensitivity and specificity reported for SMA screening kits (IntRaFast-Q)
  • +1 more outcomes

Companies that use Nuclear Laser Medicine

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles2 records

Nuclear Laser Medicine technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

Feature6 records

Nuclear Laser Medicine partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • DNA DiagnosticscoreChannel Partner/ Reseller/ Distributor · 1 January 2023NLM serves as the official Italian distributor for DNA Diagnostics, a Danish company founded in 1992 specializing in PCR and qPCR kit production for clinical and research laboratories. The partnership provides Italian customers with DNA Diagnostics' products including Hemavision 7Q and Hemavision 28Q for leukemia translocation detection using Real Time PCR technology.
  • R-biopharmcoreChannel Partner/ Reseller/ DistributorNLM distributes R-biopharm products in Italy. R-biopharm is a German company specializing in clinical diagnostics and food analysis solutions.
  • PanagenecoreChannel Partner/ Reseller/ DistributorNLM distributes Panagene products in Italy. Panagene is a Korean company specializing in molecular biology reagents and instruments.
  • ProtranscoreChannel Partner/ Reseller/ DistributorNLM distributes Protrans products in Italy. Protrans is a German company specializing in transplantation diagnostics and HLA typing solutions.
  • Blackhills Diagnostics Resources (BDR)coreChannel Partner/ Reseller/ DistributorNLM is the official Italian distributor for Blackhills Diagnostics Resources (BDR), a Spanish company. NLM distributes BDR products including the Adellgene Fragile X kit for FMR1 gene analysis. The partnership has been renewed multiple times.
  • Masmec BiomedicalminorChannel Partner/ Reseller/ DistributorNLM distributes Masmec Biomedical products in Italy. Masmec Biomedical is an Italian company specializing in biomedical instruments and diagnostics.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Nuclear Laser Medicine competitors and assessment

Company assessment

Broad incumbents

  • Bio-Rad Laboratories: Global life science and clinical diagnostics company with a broad molecular diagnostics portfolio including real-time PCR kits and instruments (e.g., CFX96) that NLM products are validated on. Comparable as a larger incumbent offering overlapping IVD menu categories to the same lab customers.
  • Cepheid (Danaher): Developer of the GeneXpert fully integrated PCR systems and broad menu of CE-marked molecular diagnostic tests for infectious disease and oncology. Comparable as a larger incumbent in automated molecular IVD workflows targeting the same hospital lab segment NLM addresses.
  • QIAGEN: Global leader in sample-preparation and PCR-based molecular diagnostic kits and automation platforms for clinical and research labs. Comparable as a broader incumbent in IVD molecular workflows, including nucleic acid extraction and PCR setup where NLM's OMNIA competes.
  • Hologic: Major molecular diagnostics company with a strong menu of women's health and infectious disease PCR assays sold to hospital and reference labs. Comparable as a broader incumbent serving overlapping clinical lab end-markets with CE-IVDR marked molecular kits.
  • Fujirebio (H.U. Group Holdings): Japanese-headquartered IVD company producing clinical diagnostics kits and instruments across infectious disease, oncology and genetic testing. Comparable as a broader incumbent with overlapping molecular IVD menu items and CE-IVDR market presence.

Direct peers

  • DNA Diagnostics: Danish manufacturer of PCR and qPCR kits for clinical and research laboratories, including leukemia translocation panels (Hemavision). Highly comparable as a small specialist peer, and also an NLM partner whose products NLM distributes in Italy.
  • DiaSorin: Italy-based IVD company focused on immunodiagnostics and molecular diagnostics, including reagents, instruments and consumables. Comparable as a domestic Italian IVD peer with an established international footprint and similarly hospital- and lab-focused channels.
  • AB Analitica: Italian IVD manufacturer focused on molecular diagnostics kits, including real-time PCR assays for infectious disease and genetic testing. Closely comparable as a small Italy-headquartered competitor serving the same clinical lab customer base with overlapping menus.
  • R-biopharm: German clinical diagnostics manufacturer producing PCR and immunoassay kits for infectious disease and food/clinical analysis. Directly comparable as a same-tier European IVD kit specialist, and NLM is already an Italian distributor for R-biopharm products.
  • ELITechGroup: European-headquartered specialist in clinical molecular diagnostics IVD kits and instruments serving hospital and independent laboratories. Closely comparable to NLM in scale, menu breadth across infectious disease and genetic testing, and distribution-led commercial model.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Nuclear Laser Medicine social profiles

Digital presence

Nuclear Laser Medicine compliance and trust

Trust signal

Compliance6 records

Nuclear Laser Medicine financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Nuclear Laser Medicine leadership team

Management profile

Number of profiles

Nuclear Laser Medicine funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Nuclear Laser Medicine M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nuclear Laser Medicine

What does Nuclear Laser Medicine do?

Nuclear Laser Medicine develops, manufactures, and distributes in vitro diagnostic kits and reagents for molecular biology laboratories, including Real Time PCR assays, fragment analysis tests, and reverse dot blot hybridization kits covering infectious diseases, genetics, oncology, and HLA applications. The company also produces the OMNIA LH 75 PRO automated workstation for nucleic acid extraction and PCR setup, and serves as the official Italian distributor for multiple international diagnostics manufacturers (DNA Diagnostics, R-biopharm, Panagene, Protrans, Blackhills Diagnostic Resources, Masmec Biomedical).

Is Nuclear Laser Medicine a public or private company?

Nuclear Laser Medicine is a private company. It is classified as unknown and is currently operating.

When was Nuclear Laser Medicine founded?

Nuclear Laser Medicine was founded in 1984. It employs 11 to 50 people.

Where is Nuclear Laser Medicine based?

Nuclear Laser Medicine is headquartered in Petralia Sottana, Italy, in the Europe region.

How does Nuclear Laser Medicine make money?

Three revenue lines are on record. Diagnostic Kits and Reagents are the primary driver. The others are automated Instruments and distribution Partnerships.

Who are Nuclear Laser Medicine's main competitors?

Broad incumbents on record are Bio-Rad Laboratories, Cepheid (Danaher), QIAGEN, Hologic and Fujirebio (H.U. Group Holdings). Direct peers are DNA Diagnostics, DiaSorin, AB Analitica, R-biopharm and ELITechGroup.

Does Nuclear Laser Medicine have an API?

No public API is recorded for Nuclear Laser Medicine.

What industry is Nuclear Laser Medicine in?

Nuclear Laser Medicine's product category is Molecular Diagnostics. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales